This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

AmeriBen / IEC Group Chooses Elsevier's MEDai

ORLANDO, Florida, October 15, 2012 /PRNewswire/ --

Risk Navigator Clinical ® to provide AmeriBen with population management  and analytics solution

Elsevier's MEDai, which empowers payers and providers to transform care delivery and streamline operations through actionable analytics, today announced a new licensing agreement with AmeriBen/IEC Group, a full-service TPA (third-party administrator) and the largest group in the Northwest possessing both human resource consulting and benefit administration services, for MEDai's Risk Navigator Clinical® software.  MEDai's Risk Navigator Clinical will assist AmeriBen, which manages more than 150,000 lives, in its population management.  

MEDai will provide AmeriBen with Risk Navigator Clinical, a robust solution to analyze and understand their care populations, and execute on strategies to improve the quality of care, reduce costs and waste, and ultimately impact health for their members.

"Risk Navigator Clinical will help AmeriBen as a TPA to promote clinical integration and care coordination in the various employee groups we serve," said Ben Wright, Chief Financial Officer and VP of Strategic Initiatives, AmeriBen.  "We are very excited to turn membership data into actionable information from which we will be able to provide improved quality, better outcomes in delivered care and reduced costs through analytical modeling to our clients."

Risk Navigator Clinical leverages predictive analytics to transform raw data into intelligent insight that payers can use to allocate resources efficiently and intervene before adverse, costly outcomes occur. Through an easy-to-use web interface, Risk Navigator's results outline areas that provide the greatest potential for intervention and management, allowing stakeholders to improve operations and set competitive premium rates.

"We are pleased to integrate Risk Navigator Clinical into AmeriBen to help it manage its clients' populations, cut costs and improve overall health though analytic modeling," said Thomas Zajac, President of Elsevier's MEDai.  "Both AmeriBen/IEC Group and MEDai believe that this relationship translates into a powerful new value proposition for the many members overseen by AmeriBen."

For more information, please visit or call +1-800-446-3324.

About AmeriBen

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $93.74 0.00%
FB $117.58 0.00%
GOOG $693.01 0.00%
TSLA $240.76 0.00%
YHOO $36.60 0.00%


Chart of I:DJI
DOW 17,773.64 -57.12 -0.32%
S&P 500 2,065.30 -10.51 -0.51%
NASDAQ 4,775.3580 -29.9330 -0.62%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs